Chemcon Speciality Chemicals Ltd (CHEMCON) AI Stock Analysis

• Market Cap: ₹9.71B
• Dividend Yield: N/A
• Average Volume (3M): 89.40K
• Price to Earnings (P/E): 38.1
• Beta (1Y): 0.85
• Revenue Growth: -7.67%
• EPS Growth: 36.60%
• Country: IN
• Employees: 220
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 1.74
• Shares Outstanding: 36,630,700
• 10 Day Avg. Volume: 238,301
• 30 Day Avg. Volume: 89,403
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹303.00
• Price Target Upside: 14.25% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 65 Neutral
• Price Target: ₹303.00 ▲(14.25% Upside)

Chemcon Speciality Chemicals Ltd's overall stock score is driven by its solid financial foundation and bullish technical indicators. However, the high P/E ratio suggests potential overvaluation, and the technical analysis indicates possible overbought conditions. The absence of earnings call data and corporate events means these factors do not influence the score.

Chemcon Speciality Chemicals Ltd Business Overview & Revenue Model

Company Description

Chemcon Speciality Chemicals Limited engages in the manufacture and sale of pharmaceutical intermediates, silanes, and oilfield chemicals in India. It offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, chloromethyl isopropyl carbonate, trimethyl chlorosilane, and hexamethyl disiloxane; and Silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane, as well as provides contract manufacturing services. The company also exports its products to United States, Italy, South Korea, Germany, the People's Republic of China, Japan, the United Arab Emirates, Serbia, Russia, Spain, Thailand, and Malaysia. The company was incorporated in 1988 and is based in Vadodara, India.

How the Company Makes Money

Chemcon Speciality Chemicals Ltd generates revenue through the manufacturing and sale of specialty chemicals, which are primarily divided into pharmaceutical intermediates and oilfield chemicals. The pharmaceutical intermediates are supplied to pharmaceutical companies for use in the production of active pharmaceutical ingredients (APIs), thus forming a significant portion of the company's income. The oilfield chemicals are utilized in oil and gas exploration activities, providing another key revenue stream. CHEMCON's revenue model is bolstered by long-term relationships with major clients, strategic partnerships, and a strong distribution network that ensures its products reach a wide range of industrial users. Additionally, the company benefits from its focus on quality and innovation, which helps in maintaining a competitive edge in the specialty chemicals market.

Chemcon Speciality Chemicals Ltd Financial Statement Overview

Summary

Chemcon Speciality Chemicals Ltd demonstrates a balanced financial performance. The income statement shows operational efficiency but highlights pressures on revenue and net profit margins. The balance sheet is strong, with a solid equity base and low leverage, fostering financial resilience. Cash flow analysis indicates efficient operational cash generation but also reveals fluctuations in free cash flow, suggesting a need for careful cash management to sustain growth and investment.

Income Statement

Chemcon Speciality Chemicals Ltd shows a mixed performance in its income statement. The gross profit margin is healthy, indicating effective cost management. However, the net profit margin and revenue growth rate have been declining, which may point to challenges in maintaining profitability. Additionally, the EBIT and EBITDA margins are solid, suggesting operational efficiency despite recent revenue contractions.

Balance Sheet

The company's balance sheet reflects a strong equity position with a low debt-to-equity ratio, suggesting financial stability and low leverage risk. The return on equity is moderate, indicating reasonable profitability relative to shareholder investments but with room for improvement. The equity ratio further underscores the company's solid financial foundation, with equity constituting a significant portion of total assets.

Cash Flow

Chemcon's cash flow statement presents a cautious picture. The operating cash flow to net income ratio is robust, indicating efficient cash generation from operations. However, the free cash flow has been volatile, showing significant fluctuations, which could impact liquidity and investment capacity. The free cash flow to net income ratio also mirrors this variability, highlighting potential challenges in sustaining cash flow levels.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2021	Dec 2021
Income Statement
Total Revenue	2.07B	2.07B	2.67B	3.03B	2.43B	2.57B
Gross Profit	724.24M	869.50M	758.95M	1.27B	1.09B	1.17B
EBITDA	438.63M	328.58M	400.64M	840.11M	852.15M	908.34M
Net Income	244.51M	244.52M	191.93M	551.10M	563.98M	627.57M
Balance Sheet
Total Assets	5.54B	5.54B	5.45B	5.53B	4.04B	4.98B
Cash, Cash Equivalents and Short-Term Investments	1.51B	1.51B	230.80M	1.35B	512.00M	1.12B
Total Debt	246.90M	246.90M	427.39M	640.15M	62.26M	360.20M
Total Liabilities	532.81M	532.81M	688.34M	959.98M	498.92M	808.06M
Stockholders Equity	5.01B	5.01B	4.76B	4.57B	3.54B	4.17B
Cash Flow
Free Cash Flow	0.00	309.45M	-308.77M	-334.54M	331.71M	241.36M
Operating Cash Flow	0.00	405.17M	119.64M	127.43M	650.30M	742.22M
Investing Cash Flow	0.00	-189.15M	-245.58M	-163.41M	-1.52B	-925.48M
Financing Cash Flow	0.00	-215.42M	-247.73M	120.41M	1.11B	298.18M

Chemcon Speciality Chemicals Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 265.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMCON, the sentiment is Positive. The current price of 265.2 is above the 20-day moving average (MA) of 235.11, above the 50-day MA of 228.95, and above the 200-day MA of 209.39, indicating a bullish trend. The MACD of 11.04 indicates Negative momentum. The RSI at 61.17 is Neutral, neither overbought nor oversold. The STOCH value of 60.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:CHEMCON.

Chemcon Speciality Chemicals Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CHEMBOND	69 Neutral	2.25B	6.83	11.25%	1.05%	-21.38%	-24.50%
SHREEPUSHK	67 Neutral	14.13B	21.16	10.88%	0.46%	16.35%	55.49%
ESTER	66 Neutral	10.82B	45.54	1.77%	0.54%	22.18%	―
CHEMCON	65 Neutral	₹9.71B	38.13	―	―	-7.67%	36.60%
HPIL	54 Neutral	1.46B	98.91	3.18%	0.39%	15.87%	15.46%
BODALCHEM	52 Neutral	7.87B	26.93	1.67%	―	19.75%	845.31%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Chemcon Speciality Chemicals Ltd Corporate Events

Chemcon Speciality Chemicals Clarifies Surge in Trading Volume

Chemcon Speciality Chemicals Ltd has experienced a significant increase in the trading volume of its securities, which the company attributes to market-driven factors beyond its control. The company has clarified that there is no undisclosed price-sensitive information or pending announcements that would influence the share price, ensuring transparency and safeguarding investor interests.

Chemcon Speciality Chemicals Ltd Announces Date for 36th AGM

Chemcon Speciality Chemicals Ltd has announced the date for its 36th Annual General Meeting (AGM), which will take place on September 11, 2025, via video conferencing. The company has set September 4, 2025, as the cut-off date to determine the eligibility of members to attend and vote at the AGM. This move aligns with regulatory compliance and ensures shareholder participation in key business decisions.